{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:33:33Z","timestamp":1759941213583,"version":"3.37.3"},"reference-count":18,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,26]],"date-time":"2017-11-26T00:00:00Z","timestamp":1511654400000},"content-version":"vor","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Foundation for Research Support of the State of Rio de Janeiro - FAPERJ","award":["E-26\/112.645\/2012"],"award-info":[{"award-number":["E-26\/112.645\/2012"]}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["449775\/2014-3"],"award-info":[{"award-number":["449775\/2014-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.vaccine.2016.11.011","type":"journal-article","created":{"date-parts":[[2016,11,12]],"date-time":"2016-11-12T21:02:26Z","timestamp":1478984546000},"page":"6116-6119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of serum bactericidal antibody and opsonic antibody levels after Neisseria meningitidis serogroup C conjugate vaccine in Brazilian children and adolescents infected or not infected with HIV"],"prefix":"10.1016","volume":"34","author":[{"given":"W\u00e2nia F.","family":"Pereira-Manfro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel M.","family":"Alvino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline C.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giselle P.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel B.N.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniella M.","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Cristina C.","family":"Frota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina B.","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucimar G.","family":"Milagres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.11.011_b0005","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1016\/j.vaccine.2011.02.058","article-title":"The global meningococcal initiative: recommendations for reducing the global burden of meningococcal disease","volume":"29","author":"Harrison","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.011_b0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1179\/016164110X12644252260754","article-title":"Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention","volume":"32","author":"S\u00e1fadi","year":"2010","journal-title":"Neurol Res"},{"key":"10.1016\/j.vaccine.2016.11.011_b0015","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.11.011_b0020","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.11.011_b0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF02918259","article-title":"Complement deficiency states and meningococcal disease","volume":"12","author":"Figueroa","year":"1993","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2016.11.011_b0030","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1128\/IAI.63.9.3531-3536.1995","article-title":"Comparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccine","volume":"63","author":"Aase","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.11.011_b0035","first-page":"485","article-title":"Opsonophagocytosis of fluorescent polystyrene beads coupled to Neisseria meningitidis serogroup A, C, Y, or W135 polysaccharide correlates with serum bactericidal activity","volume":"9","author":"Martinez","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2016.11.011_b0040","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1128\/IAI.00466-06","article-title":"Comparison and correlation of Neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac","volume":"74","author":"Findlow","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.11.011_b0045","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/CVI.00068-09","article-title":"Investigation of different group A immunoassays following one dose of meningococcal group A conjugate vaccine or A\/C polysaccharide vaccine in adults","volume":"16","author":"Findlow","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.11.011_b0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/COH.0b013e3282f269d6","article-title":"T-cell responses in primary HIV-1 infection","volume":"3","author":"Streeck","year":"2008","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.vaccine.2016.11.011_b0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00006454-200101000-00008","article-title":"Clinical Trials Group Protocol Teams 051, 128, 138, 144, 152, 179, 190, 220, 240, 245, 254, 300 and 327. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy","volume":"20","author":"Dankner","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.11.011_b0060","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1097\/INF.0000000000000630","article-title":"Immunogenicity and safety of meningococcal C conjugate vaccine in children and adolescents infected and uninfected with HIV in Rio de Janeiro, Brazil","volume":"34","author":"Frota","year":"2015","journal-title":"Pediatr Infect Dis J"},{"year":"2013","series-title":"Meningococcal: the green book, chapter 22 \u2013 Publications \u2013 GOV.UK. Immun. against Infect. Dis.","key":"10.1016\/j.vaccine.2016.11.011_b0065"},{"key":"10.1016\/j.vaccine.2016.11.011_b0070","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2016.11.011_b0075","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1097\/QAD.0000000000000007","article-title":"CD4+ T-cell activation impairs serogroup C Neisseria meningitis vaccine response in HIV-infected children","volume":"27","author":"Milagres","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2016.11.011_b0080","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1128\/IAI.69.5.3203-3213.2001","article-title":"Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry","volume":"69","author":"Plested","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.11.011_b0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0022-1759(96)00185-8","article-title":"Functional assays for evaluation of serogroup B meningococcal structures as mediators of human opsonophagocytosis","volume":"200","author":"Lehmann","year":"1997","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2016.11.011_b0090","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fimmu.2016.00310","article-title":"Linking susceptibility to infectious diseases to immune system abnormalities among HIV-exposed uninfected infants","volume":"7","author":"Ruck","year":"2016","journal-title":"Front Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16310428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16310428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T08:18:27Z","timestamp":1601194707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16310428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":18,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0264410X16310428"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of serum bactericidal antibody and opsonic antibody levels after Neisseria meningitidis serogroup C conjugate vaccine in Brazilian children and adolescents infected or not infected with HIV","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}